NOBILIS HEALTH CORP. (TSE:NHC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02
|
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. |
Senior Vice President of Finance of Nobilis Health Corp. (the
Company) since January 3, 2017, was appointed by the Board of
Directors (the Board) as the Companys new Chief Financial
Officer. Mr. Young, age 49, has over 20 years of financial and
accounting experience and has held Senior Vice President and
Chief Financial Officer positions at Fortune 500 companies.
President/Chief Financial Officer of the Americas Division for
St. Jude Medical, Inc. During his career, he has improved
profitability, increased efficiencies and successfully reduced
the overall cost structure over a span of five years at St. Jude
Medical. Prior to St. Jude, Mr. Young was Vice President of
Finance/Chief Financial Officer of Thermo Fisher Scientific where
he negotiated commercial contracts and had overall financial
responsibility for the divisions in which he worked. Mr. Young
also previously served as Vice President of Finance for Cardinal
Health where he held finance leadership roles at the division and
segment level, focusing on overall profitability, product
launches, acquisitions and integration activities. Mr. Young
began his career at KPMG and worked in a variety of finance
leadership roles. Mr. Young is a CPA and holds an MBA from
University of Texas in Austin, Texas.
15, 2016 accepted by Mr. Young, at the time of Mr. Youngs initial
employment as Senior Vice President of Finance (the Offer
Letter), Mr. Young will continue to receive an annual base salary
of $325,000, a bonus of 40% under the Companys Short-Term
Incentive Plan, and other benefits (including Company
contributions to Mr. Youngs 401(k) plan account and health
insurance premiums) in his new role as Chief Financial Officer.
Mr. Young also received a grant of stock options to purchase
200,000 common shares of the Company at the time of his initial
employment with the Company. The Offer Letter does not provide
for employment for a specified term, and Mr. Youngs employment
will be on an at-will basis.
any other person to which he was selected as an officer. Mr.
Young does not have any familial relationship with any director
or other executive officer of the Company or any person nominated
or chosen by the Company to become a director or executive
officer, and there are no transactions in which Mr. Young has an
interest requiring disclosure under Item 404(a) of Regulation
S-K.
Companys Chief Financial Officer. Mr. Klein will continue to
serve as the Companys Chief Financial Officer of the Hospital
Division, reporting directly to the Companys new Chief Financial
Officer.
announcing the matters described above, is filed as Exhibit 99.1
hereto.
|
ITEM 9.01
|
FINANCIAL STATEMENTS AND EXHIBITS
|
|
Exhibit
Number
|
Exhibit Description
|
|
99.1
|
Press Release dated February 7, 2017
|
About NOBILIS HEALTH CORP. (TSE:NHC)
Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers. The Marketing Services segment provides marketing services, patient education services and patient care co-ordination management services. The Company provides care across a range of specialties in its facilities, including orthopedic surgery, podiatric surgery, pain management, gastro-intestinal, gynecology, and general surgery. Many of its surgical patients require additional complementary healthcare services, and its suite of ancillary services, including surgical assist, intraoperative neuromonitoring and anesthesia. NOBILIS HEALTH CORP. (TSE:NHC) Recent Trading Information
NOBILIS HEALTH CORP. (TSE:NHC) closed its last trading session at 0.00000 with 733,250 shares trading hands.